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Background: DNA gyrase, an enzyme once thought to be unique to bacteria, is also found in some eukaryotic
plastids including the apicoplast of Apicomplexa such as Plasmodium falciparum and Toxoplasma gondii which are
important disease-causing organisms. DNA gyrase is an excellent target for antibacterial drugs, yet such antibacterials
seem ineffective against Apicomplexa. Characterisation of the apicoplast gyrases would be a useful step towards
understanding why this should be so. While purification of active apicoplast gyrase has proved impossible to
date, in silico analyses have allowed us to discover differences in the apicoplast proteins. The resulting predicted
structural and functional differences will be a first step towards development of apicoplast-gyrase specific inhibitors.
Results: We have carried out sequence analysis and structural predictions of the enzymes from the two species and
find that P. falciparum gyrase lacks a GyrA box, but T. gondii may retain one. All proteins contained signal/transport
peptides for localization to the apicoplast but T. gondii Gyrase B protein lacks the expected hydrophobic region. The
most significant difference is in the GyrA C-terminal domain: While the cores of the proteins, including DNA binding
and cleavage regions are essentially unchanged, both apicoplast gyrase A proteins have C-terminal domains that are
significantly larger than bacterial counterparts and are predicted to have different structures.
Conclusion: The apicoplast gyrases differ significantly from bacterial gyrases while retaining similar core domains. T.
gondii Gyrase B may have an unusual or inefficient mechanism of localisation to the apicoplast. P.falciparum gyrase,
lacks a GyrA box and is therefore likely to be inefficient in DNA supercoiling. The C-terminal domains of both apicoplast
Gyrase A proteins diverge significantly from the bacterial proteins. We predict that an additional structural element is
present in the C-terminal domain of both apicoplast Gyrase A proteins, including the possibility of a β-pinwheel with a
non-canonical number of blades. These differences undoubtedly will affect the DNA supercoiling mechanism and have
perhaps evolved to compensate for the lack of Topoisomerase IV in the apicoplast. These data will be useful first step
towards further characterisation and development of inhibitors for apicoplast gyrases.
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Apicomplexa are a group of unicellular protist parasites,
most of which contain a plastid known as the apicoplast.
Apicoplasts are the result of secondary endosymbiosis in
which a prokaryotic cyanobacterium was incorporated
into a unicellular eukaryote which was subsequently
engulfed by a second eukaryote [1,2]. As a result of this
process, the apicoplast contains the remnants of the
bacterial plasmid and has four membranes, which from* Correspondence: heddle@riken.jp
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unless otherwise stated.outside inward are the second host’s endomembrane,
the first host’s plasma membrane and the two apico-
plast membranes [2].
The Apicomplexa are of interest because they count
amongst their number several important human pathogens.
Foremost amongst these are Plasmodium species, respon-
sible for malaria, a disease which in 2010 infected approxi-
mately 200 million people resulting in over 600,000 deaths
[3] and Toxoplasma gondii which can cause dangerous
complications in the immune-compromised, is classified
by the CDC as a “neglected parasitic disease” and is
the biggest cause of death from foodborne illness in the
USA [4].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and malaria exist but are not without their drawbacks.
Most notably in the case of malaria, resistance to existing
treatments is widespread [5] and has recently come to in-
clude artemisinin, the major component of the most ef-
fective current treatment [6,7]. Progress has been made in
development of a malaria vaccine but results of large scale
clinical trials have been disappointing [8] although most
recent small scale trials do show promise [9]. Drug resist-
ance in T. gondii is also regarded as problematic [10].
Apicoplasts are known to be essential for the survival of
apicomplexan cells due to their numerous roles (reviewed
by van Dooren and Striepen [2]) these include synthesis of
heme, iron-sulfur clusters, fatty acids and isoprenoids.
The requirement for an apicoplast was initially demon-
strated in T. gondii, which was unable to survive when
apicoplast DNA replication was inhibited [11], or when
the apicoplast was absent [12]. In Plasmodium their essen-
tial function in the blood stages appears to be synthesis of
isoprenoid precursors [13].
The indispensability of the apicoplast together with fact
that it is a eubacteria-derived plastid raises the possibil-
ity of exploiting it for specific targeting of pathogenic
Apicomplexa with antibacterial drugs without affecting
the human host [14].
One of the most successful antibacterial drug targets to
date has been DNA gyrase (“gyrase”), a type II topoisom-
erase that has the unique ability to carry out ATP-
dependent negative supercoiling of DNA [15]. Gyrase
consists of GyrA and GyrB proteins with the functional
enzyme being an A2B2 heterotetramer. The supercoiling
mechanism [16] is complex and includes a step in which
the enzyme produces a transient double-stranded break in
the substrate DNA (see Figure 1). GyrA consists of an N-
terminal domain which contains a DNA binding region
and the active site tyrosine, involved in DNA cleavage via
formation of a phosphotyrosine bond and a C-terminal
domain (CTD) that wraps DNA with the appropriate
handedness for negative supercoil generation and delivers
it to GyrB. The CTD structure responsible for this wrap-
ping is termed a β-pinwheel fold [17]. This is similar to
the β-propeller fold [18] overall but with different top-
ology in its repeating units (“blades”). GyrB consists of an
N-terminal domain containing the region responsible for
ATP binding and hydrolysis and the transducer region
which connects the ATPase domain to the TOPRIM
(topoisomerase-primase [19]) domain. The C-terminal re-
gion of GyrB contains the TOPRIM domain involved in
the DNA cleavage reaction (Figure 1).
Gyrase poisons work by inhibiting the religation of
cleaved DNA, leading to fragmentation and cell death.
The highly successful fluoroquinolone class of antibac-
terials function in this way and also target topoisomer-
ase IV (“topo IV”), a closely related bacterial type IItopoisomerase, in the same fashion. Topo IV itself is
structurally highly similar to DNA gyrase, also func-
tioning as a heterotetramer (ParC2, ParE2). Like gyrase
it requires ATP hydrolysis to carry out its function,
which is mainly decatenation of daughter chromosomes
rather than negative supercoiling. Differences in the C-
terminal domain of GyrA/ParC subunits appear to ac-
count for this difference in function [22].
Until recently, gyrase was thought to occur only in bac-
terial cells. It is now known that, while apparently not oc-
curring in humans and most other higher eukaryotes, it is
found in plant plastids [23]. A malarial gyrase, whose ex-
istence had long been suggested by evidence such as the
activity of fluoroquinolones against Plasmodium and T.
gondii [11,24-27], was finally shown to exist through se-
quencing of the P. falciparum genome [28] and is local-
ized to the apicoplast. Apicoplast gyrase has been
mooted as a potentially useful therapeutic target [14,29]
although fluoroquinolone activity in vitro culture is
usually much higher than in an infected host where re-
sults are variable. In the case of in vitro experiments
with T. gondii for example, ciprofloxacin (CFX) has an
IC50 of 27.9 μg/ml [30] and in the case of P. falciparum
in in vitro culture, initial results suggested an IC50 for
CFX of 1.7 μg/ml for 24-hour experiments [26]. Mah-
moudi et al. carried out a comprehensive in vitro test of
25 quinolones and fluoroquinolones against blood stages
of P. falciparum [31] and found an IC50 for CFX of ap-
proximately 9.2 μg/ml and 3.4 μg/ml against chloroquine
sensitive and resistant strains respectively. These numbers
compare to IC50s for CFX against E. coli in the approxi-
mate range of 0.011-0.015 μg/ml [32].
Interestingly, the way in which CFX affects T. gondii ap-
pears different to the effect on P. falciparum as T. gondii
shows a clear “delayed death” where extending treatment
time lowers the IC50, something which appears not to
occur in P. falciparum for CFX [33] although it is seen for
some other molecules.
There is much less information regarding the effective-
ness of these drugs against the pathogens in an infected
host (“in vivo”). CFX, while active against T. gondii in
in vitro culture, apparently shows little effect against the
parasite in vivo [27]. In contrast, the fluoroquinolone tro-
vafloxacin is unusual in that it does show in vivo activity
[27]. Poor in vivo performance in general could be related
to complications caused by parasite life cycle or simply
the additional physical barriers in place in the host cell.
Differences could also be due to differences in structure
or mechanism of action of the enzymes themselves.
Mature T. gondii gyrase (Tg-gyrase) is 142% the size of
E. coli gyrase (Ec-gyrase) in terms of number of amino
acids and P. falciparum gyrase (Pf-gyrase) is 116%, giv-
ing much scope for potential deviation from the E. coli
“norm”. To understand the poor effectiveness of gyrase-
Figure 1 Comparison of gyrase proteins and mechanism of enzyme action. (A) Domains and secondary structures predicted from amino
acid sequences of GyrA and GyrB from E. coli, P. falciparum, and T. gondii GT1. Proteins are depicted at constant length regardless of their actual
molecular weight. Domains were predicted by Pfam [20] and secondary structures were predicted by the SOPMA server [21]. (B) Schematic
mechanism of supercoiling by DNA gyrase: (i) GyrB and GyrA dimers assemble on a piece of DNA. (ii) A protein-DNA complex is formed when
the G-segment (“G”) binds to the active site of the enzyme at the DNA gate (“D”). (iii) The N-terminal regions of GyrB (shown in purple, “N”) dimerize
upon ATP binding and capture the T-segment (“T”). The G segment is cleaved across both strands. This cleaved conformation is trapped by gyrase poisons
such as the fluoroquinolones (FQ) and is lethal to the cell. (iv) The DNA gate is opened and the T-segment is transported into the lower cavity of the enzyme.
(v) The exit gate (“E”) of the enzyme opens and the T-segment passes out. A single cycle of supercoiling is complete while two ATP
are hydrolyzed.
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portant to biochemically and biophysically characterize
purified Pf- and Tg-gyrases in vitro.Despite problems in expression and purification of Pf-
gyrase proteins, some biochemical experimental work has
been carried out utilising various domains (summarised in
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ATPase activity which was found to be DNA-stimulated
[34,35] and shows a Kcat similar to that reported for the
43 kDa domain of Ec-GyrB [34,36]. An N-terminal region
of Pf-GyrB (residues 121–497, equivalent to the Ec-GyrB
43 kDa ATPase domain) has also been produced and char-
acterized and shows ATP hydrolysis activity at a some-
what lower rate than its E. coli counterpart [35].
Pf-GyrB also shows ATP-hydrolysis and DNA supercoil-
ing activities when complemented with Ec-GyrA [35]. Fur-
thermore the enzyme appears resistant to drugs that
function by disrupting the ATP-binding site with the Ki
value of coumermycin reported to be 500 times that of
the E. coli protein [35] and the Ki value of novobiocin be-
ing approximately 3.5 times higher for Pf-GyrB compared
to Ec-GyrB [34].
While full-length Pf-GyrA (residues 156–1222) has not
been successfully expressed and purified, it has proved
possible to produce the N-terminal DNA cleavage-
reunion domain (residues 163–540) [35]. This domain
shows CaCl2-induced and CFX-induced DNA cleavage
when combined with Pf-GyrB [35]. The expression and
characterization of the full-length CTD of Pf-GyrA has
not been reported to date, although an N-terminal por-
tion of it (residues 723–887) has been produced [35].
The lack of a purified full length Pf-GyrA has undoubt-
edly hampered progress in understanding Pf-gyrase. Still
less is known of the Tg-gyrase proteins, the purification of
which has not been reported to date (as is the case for all
other apicomplexan gyrases). If these enzymes could be
purified and characterized biochemically and structurally
in comparison with standard eubacterial gyrase the data
generated could help in the design of new inhibitors and
may also point to a better understanding of the mechan-
ism of action of gyrase itself.Table 1 Summary of experiments previously carried out with
















GyrB Pf-GyrA NTD DNA cleavage Introdu
Supercoiling Failed
GyrA NTD Ec-GyrB (full length) DNA cleavage IntroduIn terms of structure, alignments for P. falciparum
have suggested a close match between the 43 kDa N-
terminal GyrB domain of Ec-gyrase containing the
ATP-binding and hydrolysis site and the equivalent re-
gion of Pf-GyrB and between the 59 kDa N-terminal
cleavage-reunion domain of Ec-GyrA and equivalent re-
gion of Pf-GyrA [34]. However, to the best of our
knowledge such alignments have not been carried out
for the C-terminal regions of Pf-GyrA and GyrB which
is where the majority of sequence divergence is located.
Tg-gyrase proteins appear never to have been subject to
structural prediction studies.
Until purified holoenzymes become available, in silico
approaches may be useful. Here we have used sequence
analysis and structural alignments/predictions to com-
pare DNA gyrase from P. falciparum and T. gondii to
known bacterial enzymes (Table 2). Ultimate verification
will of course require biochemical experiments but we
hope that these initial results will spur further investiga-
tions into these interesting gyrases.
We show that the apicomplexan gyrases, as well as the
obvious differences in size, contain signal and transloca-
tion peptides, which differ according to protein and spe-
cies. Pf-gyrases contain numerous asparagines including
repeat sequences. Perhaps the most significant differ-
ences between the proteins are found at the GyrA CTD,
which varies significantly in size compared to the bacter-
ial counterparts from which they show considerable di-
vergence. We speculate that this divergence may include
a DNA wrapping β-pinwheel domain with a different
size/number of blades than has been seen to date in all
known gyrases and/or an additional domain of unknown
function. These differences may be related to modula-
tion of supercoiling control in apicoplasts, which are not
known to contain topoisomerase IV.P. falciparum gyrase proteins
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Table 2 Summary of the protein sequences used in this study
GyrA
Organism Protein length Molecular weight (Da) Accession number
E. coli 875 96977.3 [GenBank: ACI81094]
M. tuberculosis 838 92345.1 [GenBank: AFR90340]
S. aureus 889 99624.9 [GenBank: NP_373244]
S. enterica 878 97020.9 [GenBank: WP_001281283]
X. campestris 899 99027.3 [GenBank: WP_010366603]
P. cynomolgi 1266 141638.6 [GenBank: P_004225009]
P. falciparum 1222 143144.1 [GenBank: AAN36310]
P. knowlesi 1173 133858.5 [GenBank: XP_002262302]
P. vivax 1263 144004.5 [GenBank: EDL47594]
T. gondii GT1 1594 175836.3 [GenBank: EPR58555]
T. gondii ME49 1278 142457.1 [GenBank: XP_002369962]
E. coli (ParC) 752 83831.0 [GenBank: NP_289596]
GyrB
Organism Protein length Molecular weight (Da) Accession number
E. coli 804 89866.6 [GenBank: BAA20341]
M. tuberculosis 686 75323.9 [GenBank: NP_334414]
S. aureus 644 72523.7 [GenBank: NP_373243 ]
S. enterica 826 92159.9 [GenBank: WP_006542968]
X. campestris 814 89688.5 [GenBank: WP_010376402]
P. cynomolgi 908 102112.0 [GenBank: XP_004225170]
P. falciparum 1006 116106.2 [GenBank: AAN36469]
P. knowlesi 992 112346.0 [GenBank: XP_002262476]
P. vivax 936 104905.8 [GenBank: EDL44204]
T. gondii GT1 1386 148239.4 [GenBank: EPR58339]
T. gondii ME49 1257 134533.3 [GenBank: XP_002371198 ]
E. coli (ParE) 630 70243.7 [GenBank: NP_417502]
Accession numbers were retrieved from NCBI (http://www.ncbi.nlm.nih.gov/).
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Sequence comparisons
Sequence analyses of GyrA
Bioinformatics analyses were carried out in order to gain
deeper insights into the unique properties of Pf- and Tg-
gyrases. Sequence alignments for Tg- and Pf- GyrAs and
GyrBs all aligned best with topo IV structures. This
likely reflects the lack of structural data for the relevant
regions of gyrase proteins (i.e. full length GyrB and
GyrA including the C-terminal DNA wrapping domains)
rather than an indication that the structures actually
more closely resemble E. coli topo IV.
Amino acid sequences of diverse gyrases were analysed
using the MEGA analysis software [38]. Examples of sev-
eral bacterial GyrAs and GyrBs were compared to exam-
ples from Plasmodium species along with sequences
from T. gondii and E. coli topoisomerase IV. Two ana-
lyses were carried out. Firstly pairwise distances betweensequences were calculated (Additional file 1: Tables S1
and S2). These showed that for gyrases, the differences
in amino acid sequences were greatest between the bac-
terial gyrases and the Plasmodium gyrases for both GyrA
and GyrB. Topoisomerase IV, as would be expected, was
also the most different in the case of ParE compared to
GyrBs, but in fact less different than the Plasmodium
GyrA proteins in the case of ParC. Tg-GyrA fell between
bacterial and Plasmodium sequences in terms of differ-
ence and Tg-GyrB was similar to Plasmodium proteins.
The maximum parsimony bootstrap consensus trees for
the proteins show a similar result with two clear clusters,
one for bacterial proteins and another for Plasmodium
proteins with topoisomerase IV and T. gondii gyrases be-
ing somewhat variable outliers (See Additional file 1:
Figure S1). Sequences were also aligned with ClustalW
2.1 [39,40] which showed that 25.6% of residues were
identical between Ec-GyrA and Pf-GyrA. The value
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mains identified by the Pfam server. Percentages of
identical residues for the N-terminal domain (Ec-GyrA
32–507 encompassing WHD, tower, and coiled-coil do-
mains) and the C-terminal domain (Ec-GyrA 538–840
encompassing the β-pinwheel domain) were 34.1% and
18.0%, respectively. These observations are rationalized
by lower homology of the C-terminal domain of Pf-GyrA
with respect to Ec-GyrA. Analysis of the amino acid se-
quences of Ec-GyrA using the Pfam domain prediction
server results in six β-sheet blades of the β-pinwheel motif
being predicted in accordance with reported experimental
results [41]. In contrast, only three such motifs are pre-
dicted from the Pf-GyrA sequence with the E-value set to
10, the maximum value. This prediction is consistent with
secondary structures predicted by the SOPMA structure
prediction server [21], where β-sheets are predicted for
those regions of Pf-GyrA (Figure 1A). At face value, this
suggests the presence of a small β-pinwheel domain con-
sisting of a cluster of no more than three blades (Figure 1,
Additional file 1: Figure S2). All known gyrases have 6
blades [42]. Given that individual blades in Pf-GyrA ap-
pear to be approximately the same size as those found in
other gyrases, it is difficult to envisage three blades alone
to wrap DNA with a sufficiently acute angle to deliver it
to the DNA clamp. Two possible explanations are that i)
Pf-GyrA may be an example of a topo II with fewer than
six β-pinwheel motifs (as is seen for E. coli topo IV [42]).
ii) Pf-GyrA does in fact contain a β-pinwheel with a larger
number of blades but they are of a sequence highly diver-
gent from known structures and are thus not recognised
by Pfam. For Tg-GyrA, the percentage of identical resi-
dues to Ec-GyrA is 33.5%. In terms of the distribution of
identical residues, similarity can be observed to that seen
between Ec-GyrA and Pf-GyrA, i.e. a higher identity is
found in the N-terminal domain (41.5%) compared to the
C-terminal domain (26.7%).
The N-terminal 59 kDa fragment of Ec-GyrA bears a
domain similar to the DNA-binding domain of the
catabolite-activator protein (CAP) containing a helix-turn-
helix (HTH) motif and the tower domain [43]. A hallmark
of topoisomerase, the active site tyrosine that forms a
transient phosphodiester bond with the end of the G-
segment DNA is found in the HTH motif, which is part of
the positively charged groove. A cluster of conserved resi-
dues comprises the active site of Ec-GyrA based on the
crystal structure of the 59 kDa fragment. Those residues
(Ec-GyrA Arg32, Lys42, Arg46, Arg47, Arg121, Tyr122)
are perfectly conserved among Pf- and Tg- GyrAs, consist-
ent with their role and confirming that the cleavage-
reunion domain likely functions in an identical manner to
that of other gyrases.
Next, the “GyrA-box” and its vicinity were considered.
The GyrA-box is a positively charged motif (SequenceQ++GG + G, where + is any positively charged residue
[42]) found in blade 1 of the β-pinwheel of the GyrA CTD
and is known to be necessary for DNA supercoiling and
wrapping [44,45]. GyrA from species such as E. coli have a
conserved proline at position 636 (Ec-GyrA numbering)
close to the hinge between blades 1 and 2 and this was
thought to introduce a tilt in the packing between blades,
causing the pinwheel to be out of plane, giving positive
handedness to the DNA wrap [46]. Deletion of this proline
in Ec-GyrA leads to a 2-3-fold decrease in supercoiling ac-
tivity [46]. In some other species lacking the proline, such
as B. burdorferi, the CTD is planar [17]. It is also planar in
the case of 6-bladed Topo IV CTDs [47]. However, in M.
tuberculosis gyrase, there is no conserved proline and yet
the CTD is tilted [48]. These results suggest that other
mechanisms in addition to/instead of the “conserved” pro-
line are responsible for the non-planar shape.
Our alignments (Figure 2, Additional file 1: Figure S2)
show that Pf-GyrA lacks a GyrA-box while a potential
GyrA-box is present in Tg-GyrA (as a 996-RRGALGV-
1006 motif similar to the canonical sequence found in E.
coli). It is notable that this Tg-GyrA box does not coincide
with blade sequences as predicted by Pfam (Additional
file 1: Figure S2) although it does coincide with the location
of a β-pinwheel as predicted by I-TASSER when the
sequence of Tg-GyrA CTD is submitted (see below).
Interestingly, the sequence in place of the GyrA-box in
Pf-GyrA has a negative charge (Pf-GyrA Asn821-Ser913
pI: 5.50). This stands out among other Plasmodium se-
quences in this region, which have pIs ranging between
7.19 and 8.17. The loop region containing the GyrA-box
in Ec-GyrA (Ser555-Asp576) has a high pI of 8.16. The
corresponding region of Tg-GyrA (Ser990-Ala1039) is
similarly positively charged with its pI at 8.69, which is in
contrast to that of Pf-GyrA (Asn821–Tyr914, pI: 5.38). Pf-
GyrA and Tg-GyrA both have apicoplast specific inser-
tions in the region C-terminal to the GyrA-box (71 and 30
additional residues compared to Ec-GyrA, respectively).
The moderately conserved proline (Ec-GyrA Pro636), is
not present in either Plasmodium nor Toxoplasma gyr-
ases. As a consequence of the lack of the GyrA box in
Pf-gyrase we may expect that it is unable to efficiently
supercoil DNA (as has been found for other gyrases lack-
ing a GyrA box [44]). In the case of Tg-GyrA, four β-
pinwheel blades predicted by Pfam are spread throughout
the C-terminal region rather than being clustered to-
gether. In contrast, the homology model based on the ma-
ture amino acid sequence of Tg-GyrA by I-TASSER
suggests that the majority of the β-pinwheel blades are lo-
cated N-terminal to those predicted by Pfam.
Sequence analyses of GyrB
The overall percentage of identical residues between Ec-
GyrB and Pf-GyrB was 38.5%. Unlike the case of Ec-GyrA
Figure 2 Locations of asparagine repeats in P. falciparum gyrase genes and the structures of E. coli gyrases containing the
corresponding regions. (A) The asparagine-repeat of Pf-GyrA is located in a region close to the region corresponding to the GyrA box of prokaryotic
gyrases. This region often appears disordered in crystal structures. Two residues (Ser555 and Asp576) flanking the disordered region containing the
GyrA box (560-QRRGGKG-566) are highlighted by magenta spheres (PDB code 1ZI0 [41] chain A). (B) The asparagine-repeat is encompassed in
the Plasmodium specific insertion of gyrase B. The region corresponds to the ATP lid of Ec-GyrB, highlighted by magenta on the 24 kDa fragment
structure (PDB code 1AJ6 [49]).
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throughout the length of the proteins. The percentage of
identical residues at the N-terminal domain (E. coli 31–
391) is 35.7%, whereas for the C-terminal domain (E. coli
419–793) it is 40.7%. The percentage of identical residues
between Ec-GyrB and Tg-GyrB is 35.1% (N-terminal do-
main: 35.6%, C-terminal domain: 32.9%).
Interestingly, Pf-GyrB includes an insertion of 45 amino
acids in its TOPRIM domain which is essential for activity
[37]. This same insert is present in all Plasmodium species
but is absent from the other 9 GyrB genes we considered.
Our alignments also confirmed a 49-amino acid insert in
part of the ATPase domain corresponding to the ATP lid
of Ec-GyrB (Figure 2). We find that this insert, which has
been noted previously [34] is unique to Plasmodium
GyrBs amongst the proteins we investigated.Size comparison
The most striking difference between the proteins in com-
parison to their E. coli counterparts is in overall size. GyrA
and GyrB in E. coli are 875 and 804 amino acids in length
respectively; in Pf-gyrase the lengths of mature proteins
are 1067 and 886 amino acids respectively while in Tg-
gyrase they are 1336 and 1041 amino acids respectively.
The “extra” sequences in the apicomplexan gyrases are
not entirely devoid of secondary structure as predicted
by SOPMA [21] (Figure 1A, Figure 3). Those additional
structural elements could confer unique properties to
apicoplast gyrases, for example a 45 amino acid inser-
tion in the TOPRIM domain of Pf-GyrB known to play
a role in ATPase activity, DNA binding, and DNA
cleavage [37]. There are cases, however, where the non-
homologous regions are predicted to form low complexity
Figure 3 Analyses of the signal/transit peptides of apicomplexan gyrase sequences. Secondary structure prediction and hydrophobicity
plot of residues 1–155 of Pf-GyrA (A) and residues 1–120 of Pf-GyrB (B). Both sequences feature hydrophobic α-helices in the N-terminus. Secondary
structure prediction and hydrophobicity plot of residues 1–259 of Tg-GyrA (C) and residues 1–261 of Tg-GyrB (D). On the contrary to other proteins,
Tg-GyrB does not feature a hydrophobic region in its N-terminus.
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due repeats. The P. falciparum proteome has previously
been reported to be rich in asparagine repeats [50,51].
The feature is partially attributed to its AT-rich genome,
but asparagine repeats are not found in other species of
equally AT-rich Plasmodium spp. [51]. Asparagine repeats
are thought to render the proteome susceptible to forming
intracellular aggregates, but given the presence of a potent
Hsp110 and other chaperones, they may provide a positive
selective pressure by playing a role in immune evasion[52,53]. The proportion of asparagine residues in the cod-
ing sequences of gyrase A and B were compared between
four species in the Plasmodium genus: P. falciparum, P.
vivax, P. cinomolgi, and P. knowlesi (Table 3). It is clear
that the gyrase genes of P. falciparum encode the highest
proportion of asparagine in accordance with Muralidharan
and Goldberg [51]. Additionally, not only do Pf-gyrase
proteins feature a quantitatively higher proportion of as-
paragine residues, but they are qualitatively unique be-
cause Pf-GyrA and Pf-GyrB each have regions where
Table 3 Proportions of asparagine residues in the coding
sequences of gyrases A and B in four species of
Plasmodium
P. falciparum P. vivax P. cynomolgi P. knowlesi
Gyrase A 14.65 (10.97) 7.44 7.98 9.04
Gyrase B 13.72 (10.83) 10.15 8.04 7.56
Figures are given in percentages (%). The figures in parentheses for P. falciparum
are proportions of asparagine residues in the signal peptides (Pf-GyrA: 1–155,
Pf-GyrB: 1–120).
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Figure S3). For Pf-GyrB this region (253–261) is located
in the area corresponding to the ATP-lid of the GHKL
Bergerat fold of the ATPase domain [54], whereas in
Pf-GyrA the repeat (888–902) is located in the region
that corresponds to the GyrA box of the C-terminal
33 kDa fragments in prokaryotic GyrA. In both cases
the repeats are located in areas corresponding to loop
regions in the predicted structures (Figure 2).
In contrast to Pf-gyrases, Tg-gyrases are rich in ser-
ines (Table 4). Unlike the asparagine repeats in Pf-gyrases,
these serine repeats are primarily concentrated in the
N-terminal signal peptide regions (Additional file 1:
Figure S4). Additionally, Tg-GyrB has a serine repeat in
a region, which equates to the transducer domain of E.
coli GyrB 43 kDa fragment.
We also compared the signal and transit peptides of the
proteins. A typical apicoplast-targeting protein contains
an N-terminal signal peptide followed by the apicoplast
transit peptide for protein import into the apicoplast [55].
The amino acid sequence varies in transit peptides from
different apicomplexans, for example, lysine is common in
P. falciparum while arginine is common in T. gondii
[56,57]. Those basic residues near the N-terminus of the
transit peptide are reported to be important for faithful
transport into the apicoplast and an algorithm has been
established to identify the signal and transit peptides in
multiple Apicomplexa species [58]. We analyzed N-
terminal regions of Plasmodium and Toxoplasma gyr-
ases that are expected to play key roles in translocation.
Submission of Plasmodium and Toxoplasma gyrase se-
quences to the SOPMA [21] and Protscale [59] servers
results in identification of a short hydrophobic α-helix
predicted for each Plasmodium gyrase gene (Figure 3).Table 4 Proportion of serine resides in gyrases of T.
gondii GT1 with respect to the full-length sequence and
the signal peptide
Full length protein Signal peptide
GyrA 1 – 1594, 9.91% 1 – 258, 23.26%
GyrB 1 – 1386, 20.06% 1 – 345, 40.58%
Signal peptide of T. gondii GT1 gyrases were inferred from aligned sequences
(Additional file 1: Figure S5). Residue numbers are shown, followed by the
proportion of serine residues as apercentage.This is consistent with previous work showing that the
signal peptides of apicoplast-targeted proteins in P. falcip-
arum comprise a hydrophobic region [60]. In contrast,
analyses of the Tg-GyrB sequence indicate different char-
acteristics at the N-terminal region (Figure 3): Surprisingly
for a protein that is predicted to be translocated to the
apicoplast, the N-terminal signal peptide of Tg-GyrB is
markedly non-hydrophobic which is in contrast to Tg-
GyrA, Pf-GyrA and Pf-GyrB. This observation could
imply an inefficient direction of Tg-GyrB across the
endoplasmic reticulum in the first step of the secretory
pathway.
Structure prediction and alignments
GyrA
Homology modelling of full-length Pf-GyrA (minus the
signal and transit peptide sequences) was carried out
using I-TASSER [61,62]. The protein was predicted to
align well with a number of known GyrA/ParC struc-
tures (see Additional file 1: Table S3) with the structure
of full-length ParC from E. coli (1ZVU [42]) ranking top.
Figure 4A shows the alignment between the predicted
Pf-GyrA structure and ParC. The rmsd was 1.37 Å. The
alignment shows that the N-terminus of Pf-GyrA ap-
proximately equivalent to the 59 kDa region of E. coli
GyrA aligns well with E. coli ParC, including the DNA
breakage-reunion site, the coiled-coil region and the C-
gate.
Pf-GyrA CTD structure prediction by I-TASSER dif-
fers from Pfam results in that residues identified by
Pfam as part of the β-pinwheels in the CTD (residues
978–1121, shown in orange in Figure 4A) do not align
with the equivalent structure in ParC but residues 710–
968 do align with the 5-bladed ParC pinwheel. Given
that the two predicted regions do not overlap, it may be
that the actual structure consists of a large β-pinwheel
consisting of both regions combined resulting in eight
blades. This would be unusual as all gyrase β-pinwheels
known have six blades. The equivalent region of topo IV
in various organisms is more variable and includes both
3-bladed and 8-bladed pinwheels [42].
This inconsistency is attributable to a constraint to the
structural homology calculations that derives from the
fact that the ParC template structure features the pin-
wheel domain immediately C-terminal to the N-terminal
domain. In order to create a homology model of the C-
terminal domain of Pf-GyrA without such constraint,
the sequence of the C-terminal region (671–1222) was
submitted to I-TASSER on its own. This results in the
pinwheel domain being predicted in a region different
from when the fuller sequence is submitted (Figure 4B).
Homology models based on the five best templates con-
sistently features the β-pinwheel domains beginning in
residues 875–877 and ending in residues 1220–1222
Figure 4 Homology models of Pf-GyrA and Tg-GyrA by I-TASSER. (A) Alignment of Pf-GyrA with Ec-ParC (1ZVU [21]). One monomer of ParC
is dark grey, the other is cyan for ParC with the β-pinwheel (497-740) colored purple. One monomer of Pf-GyrA is light grey and the other
colored according to the results of the Pfam prediction as follows: N-terminal residues 196-667 are in dark blue, and the predicted β-pinwheel
blades (538-840) are orange and in stick representation. The remaining sequences, which are not predicted to have any secondary structure, are
red. Right hand side is the same alignment as A but rotated 90° around the y axis. (B) Alignment of the CTD (671-1222) of Pf-GyrA with Ec-ParC
(1ZVU). Part of the model aligns with the a-helical bundle of the template, but is likely due to a-helices being predicted in that region of Pf-GyrA,
rather than specific homology to the region in the template. (C) Alignment of Tg-GyrA with Ec-ParC. One monomer of ParC is dark grey, the
other monomer is cyan for ParC with the β-pinwheel (497-740) colored purple. One monomer of Pf-GyrA is light grey and the other is colored
according to the results of the Pfam prediction as follows: N-terminal residues 297-770 are dark blue, and the predicted β-pinwheel blades
(1052-1086, 1323-1371, 1405-1446 and 1523-1564) are orange and in stick representation. The likely GyrA-box of Tg-GyrA is shown as green
spheres. The remaining sequences that are not predicted to have any secondary structure are red. Right hand side is the same alignment as C
but rotated 90° around the y axis. (D) Alignment of the CTD (775-1594) of Tg-GyrA with the template (3L6V). As for Pf-GyrA, a-helices are also
predicted N-terminal to the b-pinwheel motifs.
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blades predicted by I-TASSER using the mature sequence,
to give a total of 6 blades. Also, the five best models con-
sistently feature α-helices between residues 698–848. This
is qualitatively similar to the prediction made by Dar et al.
[35] in predicting a coiled-coil between the NTD and the
CTD of GyrA, and hence legitimises the prediction of anadditional structural element in Plasmodium GyrA com-
pared to bacterial counterparts.
When the full length Tg-GyrA sequence (omitting the
signal and transit sequences) was submitted to I-TASSER,
the results as shown in Figure 4C were obtained. As with
Pf-GyrA, the protein aligned best with the same E. coli
ParC structure (pdb 1ZVU [42]). The rmsd was 1.91 Å.
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alignment with the cleavage reunion and N-terminal
portion of ParC. In addition, of the residues identified
as β-pinwheel blades by Pfam; (1052–1086, 1323–1371,
1405–1446 and 1523–1564) only the most N-terminal
(1052–1086) overlaps with the β-pinwheel blades of
ParC, the others being dispersed throughout the C-
terminus in regions not aligned with any part of the
ParC structure. Interestingly, the region predicted to be
the most N-terminal blade is not recognized as any do-
main/motif by Pfam. The I-TASSER alignment places
unaligned, largely unstructured sequences both N and
C-terminal to the β-pinwheel. The C-terminal 500 resi-
dues beginning at residue A1096 of Tg-GyrA were not
assigned as corresponding to any existing structure in
ParC by I-TASSER. Similarly to Pf-GyrA, the sequence
of the C-terminal region of Tg-GyrA (775–1594) was
submitted to I-TASSER on its own (Figure 4D). The
models based on the top four templates consistently
predict α-helices in residue range of 788–945, followed
by β-pinwheel motifs between 974–1505. The latter
range only covers three out of four blades predicted by
Pfam but, as for the CTD of Pf-GyrA, a total of 6 β-
pinwheel blades is predicted in total. Clearly, the details
of precisely which parts of the C-terminus are predicted
to be a pinwheel depends on the software employed
and the submitted amino acid sequence. Prediction of
α-helices N-terminal to the β-pinwheel domain is simi-
lar to the case in Pf-GyrA, and suggests the presence of
α-helices between the NTD and the CTD as being a
common element among apicomplexan GyrAs.
Homology models obtained from I-TASSER reveal lit-
tle evidence of gross structural deviation by Pf-GyrA and
Tg-GyrA at the catalytic core and its surroundings. This
is unsurprising given that the sequence identity is higher
for the N-terminal domains in both GyrA and GyrB as
described above. The most effective gyrase targeting an-
tibacterials, the fluoroquinolone gyrase poisons, bind to
a site made primarily of residues of the cleavage-reunion
domains in GyrA and bound DNA [15]. The absolute
conservation of amino acid sequence of this region in Pf
and Tg-GyrA means that the binding site for gyrase poi-
sons is likely unchanged. In Tg-GyrA, the exact start
residue of the mature protein is not fully established,
thus the possibility of a relatively large structural elem-
ent at the N-terminus is not completely ruled out.
GyrB
GyrB from P. falciparum lacking the signal and transit
peptides was submitted to I-TASSER. The structure of
full-length bacterial GyrB is not known and the align-
ment returned was best matched to a S. pneumoniae
topo IV structure 4I3H [63] consisting of full-length
ParE (equivalent to GyrB) fused to a 55 kDa region ofParC (equivalent to GyrA). The rmsd was 1.63 Å. The
results (Figure 5A) shows that there is good structural
homology overall with only a small number of continu-
ous non-homologous regions. One interesting example
is a region in the vicinity of the unique 49 amino acid
insert (Pf-GyrB 224–272) previously identified in the
ATP lid [34] (Figure 5A). Previous alignments suggested
the 49 amino acid insert to be flanked by regions with
high homology to other known GyrB sequences and form
an unstructured loop [34]. On the contrary, the homology
modelling by I-TASSER predicts the residues 225–320 to
form a loop region (highlighted in Figure 5A). This in-
consistency is likely an instance of “loop swapping” (see
Methods section).
Tg-GyrB was also submitted to I-TASSER and like Pf-
GyrB aligns well with the same S. pneumoniae topo IV
structure 4I3H [63] with an rmsd of 1.14 Å. Due to its
extra length, Tg-GyrB contains a greater number of lon-
ger, unassigned loops. These loop regions are clustered
around the GHKL region (Figure 5B). Overall, in both
Pf- and Tg-GyrBs core domains seem to be largely pre-
served and this includes the regions involved in DNA
binding (Figure 5).
GyrB contains the ATPase domain and it is clear from
the aligned sequences of these domains that many key
motifs are conserved between bacterial and apicoplast gyr-
ases (Figure 6). Motifs conserved among GHKL fold
termed N (uubEuuaNouDa), G1 (uxuxDNGxGuxbaaux-
xuu), G2 (uGxxGxouxSxxxuoxbuTuxT), and G3-box
(TxnGT) can be identified (u, conserved bulky hydro-
phobic residues; b, basic residues; a, acidic residues)
[54]. Indeed the ATPase activities of Pf-GyrB have been
demonstrated [35,37,64]. The sequence of the GyrB
subunit especially the ATP binding pocket is highly
conserved among bacterial and apicoplast gyrases. For
example, the residues located in a structural pocket, in-
cluding N46, E50, R76, I78, K103, V118, and T165 known
for ATP binding and ATPase inhibitors binding in Ec-
GyrB [65] are conserved in Pf-GyrB. Two residues in-
volved in the quinolone-binding pocket (also called
quinolone resistance-determining region, QRDR [66,67]),
N426 and K447 of Ec-GyrB are also conserved in Pf-GyrB.
The similarity in drug interacting residues may explain the
observation that known gyrase-targeting antibacterials
drugs can show similar effects toward Pf-gyrase in ATPase
activity and DNA cleavage activity assays [34,35]. A sig-
nificant divergence is seen in Pf-GyrB where an inser-
tion is present in the “lid” region covering the ATP
binding site [34] (see below). In Tg-GyrB the clustering
of continuous non-assigned sequences around the GHKL
domain hints that this region is most structurally diver-
gent and may even point to the presence of an add-
itional domain. ATP binding and/or hydrolysis may
also be affected in Pf-GyrB due to the insert in the ATP
Figure 5 Homology models of Pf-GyrB and Tg-GyrB by I-TASSER. (A) Alignment of Pf-GyrB with topoisomerase IV complexed with DNA (pdb
4I3YH [63]). One monomer of the topo IV dimer is shown in dark grey, the other in cyan. One monomer of the Pf-GyrB is colored light grey, the
other is colored as follows (numbering includes the signal and translocation peptide) residues 148–340 (roughly equivalent to GHKL domain), purple,
residues 704–875 (roughly equivalent to the transducer domain, green) residues 910–1195 (roughly equivalent to TOPRIM and C-terminal tail), yellow.
Unassigned sequence is shown in red. DNA bound to the DNA cleavage region is shown in stick format. Other DNA is removed for clarity. Bracketed
loop is a Plasmodium specific insert. (B) Alignment of Tg-GyrB with Topoisomerase IV complex with DNA (pdb 4I3YH [63]). Coloring is as follows:
Residues 291–876 (roughly equivalent to GHKL and transducer domains), purple, residues 910–1258 (roughly equivalent to TOPRIM and C-terminal tail),
yellow. Unassigned sequence is shown in red. DNA bound to the DNA cleavage region is shown in stick format. Other DNA is removed for clarity. For
each presentation, an alternative view rotated horizontally by 90° is shown on right hand side.
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compared to Ec-GyrB [35]. Indeed it has previously
been speculated that the presence of unstructured loop
regions in the ATPase domain may affect ATPase activ-
ity and the effectiveness of inhibitors, which bind in
that region [34]. The extra sequence in this regionFigure 6 Conserved motifs found within the ATPase domain of gyras
although some divergence is also present.could perhaps also provide scope for binding of new
inhibitors.
Conclusions
In summary, we have carried out a comprehensive se-
quence and structural comparison of two apicomplexanes and E. coli topo IV. High degree of conservation can be observed,
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found a number of differences which may have both rele-
vance to enzyme function and consequences in terms of
effectiveness of therapeutics as well as providing useful
data for future structural studies.
While the results presented in this work are not defini-
tive there are sufficient data to enable some tentative
speculation, which should be considered in the light of re-
cent findings from M. tuberculosis: This organism also has
a gyrase but lacks topo IV. M. tuberculosis gyrase has a
greater decatenation ability relative to negative supercoil-
ing ability compared to Ec-gyrase [68,69], something
which is thought to be due to decreased DNA-stimulated
ATPase activity and a truncated “tail” in the CTD which
combine to inhibit the enzyme from achieving as high a
level of DNA duplex under-winding as the E. coli enzyme
[48]. Further research has shown that this gyrase has a cal-
cium binding site and that that gyrase in M. tuberculosis
can shift between gyrase-like and topo IV-like activities via
the modulatory action of Ca2+ which binds in the linker
region between the NTD and CTD of GyrA [70]. This is
proposed to alter the position of the β-pinwheels relative
to the remainder of the enzyme such that supercoiling
may be favored in the absence of Ca2+ while disfavored
in its presence, allowing relaxation/decantation to occur.
The fact that the greatest variation in Pf- and Tg-gyrases
compared to Ec-gyrase is in the CTD strongly suggests
that this is due to a role in affecting or modulating the bal-
ance between gyrase-like and topo IV-like activities. Tg-
gyrase, in contrast to Pf-gyrase, has a likely GyrA box but
lacks an insert in the ATP lid meaning that these mooted
activity modifiers are not available to it. In this instance,
compensation for the lack of topo IV is presumably
achieved at least in part through its unusually large GyrA
CTD, which may affect extent and/or position of the
DNA wrap. It is also the case that additional structural
elements found in Plasmodium and Toxoplasma gyrases
may be responsible for modulating their activity by
means not found in prokaryotes. These may pose an
additional target for drugs in the future. For example,
we may envisage that inhibiting the apicoplast targeting
of gyrases will be lethal to Apicomplexa.
Further biochemical studies on individual gyrase pro-
teins from these organisms as well as holoenzymes in
conjunction with high-resolution studies will be required
to answer outstanding questions and assess their suit-
ability as targets for development of therapeutics.
Methods
Sequence comparisons
Amino acid sequences of proteins were aligned with Clus-
talW 2.1 using the default parameters [39]. The percentages
of sequence identities were calculated by dividing the num-
ber of identical residues by the total aligned sequence lengthwithout insertions. Aligned sequences were viewed using
CLC Sequence Viewer (CLC bio). Aligned amino acid se-
quences of gyrase and topoisomerase IV proteins from vari-
ous species were inputted into MEGA (v. 6.06 beta) [38].
Pairwise distances between sequences were computed (the
number of amino acid differences divided by the total num-
ber of amino acids compared). Gaps and missing data were
deleted and no variance estimation method was used. A
maximum parsimony tree was calculated using the Jones-
Taylor-Thornton model assuming uniform rates among
sites. Phylogeny was tested using the bootstrap method with
500 bootstrap replications.
Structure prediction
Structure predictions were carried out using I-TASSER
[61,62]. In all cases, amino acid sequences for the proteins,
lacking the predicted signal and transit sequences were sub-
mitted to the I-TASSER server. Default settings were used
with no additional restraints employed. From the top 10
identified structural analogues returned the best alignment
was chosen based on TM-score ranking. The top ranking
alignment templates were E. coli ParC [63] for Pf-GyrA, Pf-
GyrA CTD (residues 671–1222) and Tg-GyrA, S. pneumo-
niae ParC-ParE55 fusion protein [63] for Pf-GyrB and Tg-
GyrB and X. campestris GyrA CTD for Tg-GyrA CTD (resi-
dues 775–1594). PDB coordinates were visualised using
PyMOL [71]. All of the proteins considered were signifi-
cantly longer than the homologous regions in the model
templates. This has an important consequence for the hom-
ology models generated. When additional sequences are
present then clearly not all sequences can be aligned to a
template. In some cases we observe that where sequences
flanking these loop regions themselves have poor similarity
to the template, then “loop swapping” may occur where the
flanking sequence is in fact designated a loop and the loop is
assigned structure. This does occur in parts of our structure
but has little effect on the overall model.Structural alignments
Dimeric models of homology models of the proteins as
generated by I-TASSER, were created by superposing
each homology model onto dimeric crystal structures
of the template topoisomerases using Coot [72]. The
SSM Superpose function was used, and root mean square
deviation (RMSD) of the distances between alpha carbons
of the aligned residues were calculated. This allowed us to
see regions of the Pf or Tg protein, which matched well
with a known gyrase protein structure and, more import-
antly those regions where poor homology was predicted.
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